Xencor, Inc. logo

Xencor, Inc.

NASDAQ:XNCR

Overview | Financials
Company Name Xencor, Inc.
Symbol XNCR
Currency USD
Price 16.18
Market Cap 1,000,466,030
Dividend Yield 0%
52-week-range 15.31 - 26.84
Industry Biotechnology
Sector Healthcare
CEO Dr. Bassil I. Dahiyat Ph.D.
Website https://www.xencor.com

An error occurred while fetching data.

About Xencor, Inc.

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic

Related Stocks

ModivCare Inc. logo

ModivCare Inc.

MODV

32 USD

Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

LGND

101.14 USD

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

126.37 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

41.59 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

3.38 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

184.19 USD

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

10.98 USD

Financials

Numbers are in millions USD

Numbers are in millions USD